<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id><journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id><journal-id journal-id-type="publisher-id">MEDI</journal-id><journal-title-group><journal-title>Medicine</journal-title></journal-title-group><issn pub-type="ppub">0025-7974</issn><issn pub-type="epub">1536-5964</issn><publisher><publisher-name>Wolters Kluwer Health</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5779749</article-id><article-id pub-id-type="publisher-id">MD-D-17-06386</article-id><article-id pub-id-type="doi">10.1097/MD.0000000000009575</article-id><article-id pub-id-type="art-access-id">09575</article-id><article-categories><subj-group subj-group-type="heading"><subject>5300</subject></subj-group><subj-group><subject>Research Article</subject><subject>Systematic Review and Meta-Analysis</subject></subj-group></article-categories><title-group><article-title>Efficacy of percutaneous vertebroplasty treatment of spinal tumors</article-title><subtitle>A meta-analysis</subtitle></title-group><contrib-group><contrib contrib-type="author"><name><surname>Qi</surname><given-names>Lei</given-names></name><degrees>PhD</degrees></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Chuankun</given-names></name><degrees>MD</degrees></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Ning</given-names></name><degrees>MD</degrees></contrib><contrib contrib-type="author"><name><surname>Lian</surname><given-names>Haiping</given-names></name><degrees>BS</degrees></contrib><contrib contrib-type="author"><name><surname>Lian</surname><given-names>Minxue</given-names></name><degrees>PhD</degrees></contrib><contrib contrib-type="author"><name><surname>He</surname><given-names>Baixiang</given-names></name><degrees>MD</degrees></contrib><contrib contrib-type="author"><name><surname>Bao</surname><given-names>Gang</given-names></name><degrees>PhD</degrees><xref rid="cor1" ref-type="corresp"><sup>&#x02217;</sup></xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Liu.</surname><given-names>Miao</given-names></name></contrib></contrib-group><aff>Department of neurosurgery, the First Affiliated Hospital of Xi&#x02019;an Jiaotong University, Xi&#x02019;an, China.</aff><author-notes id="cor1"><corresp><label>&#x02217;</label>Correspondence: Gang Bao, Department of Neurosurgery, the First Affiliated Hospital of Xi&#x02019;an Jiaotong University, Xi&#x02019;an 710061, China (e-mail: <email>baogang_1973@aliyun.com</email>).</corresp></author-notes><pub-date pub-type="collection"><month>1</month><year>2018</year></pub-date><pub-date pub-type="epub"><day>19</day><month>1</month><year>2018</year></pub-date><volume>97</volume><issue>3</issue><elocation-id>e9575</elocation-id><history><date date-type="received"><day>19</day><month>10</month><year>2017</year></date><date date-type="rev-recd"><day>23</day><month>11</month><year>2017</year></date><date date-type="accepted"><day>15</day><month>12</month><year>2017</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2018 the Author(s). Published by Wolters Kluwer Health, Inc.</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0">http://creativecommons.org/licenses/by-nc-nd/4.0</ext-link></license-p></license></permissions><self-uri xlink:type="simple" xlink:href="medi-97-e9575.pdf"/><abstract><title>Abstract</title><sec><title>Objective:</title><p>To evaluate the function of percutaneous vertebroplasty (PVP) treatment to pain relief and life quality for patients with spinal tumors.</p></sec><sec sec-type="methods"><title>Methods:</title><p>Articles about the researches on the treatment of spinal tumors by PVP in PubMed, Embase, and the Chinese Biomedical Literature database from January 1, 2015 to December 31, 2013. The keywords &#x0201c;spinal tumors,&#x0201d; &#x0201c;efficacy,&#x0201d; and &#x0201c;vertebroplasty&#x0201d; were firstly scanned to exclude all irrelevant articles. Then, the final inclusion of studies was determined by reading the full text of the remaining articles. The citation lists of all retrieved articles were scanned to identify other potentially relevant reports. RevMan5.2 was used to analyze pain intensity visual analog scale (VAS) and Karnofsky performance scores (KPS) within each research. Combined HRs (hazard ratio) were calculated using fixed- or random- effects models according to the heterogeneity.</p></sec><sec sec-type="results"><title>Results:</title><p>Twenty-six studies involving 1351 patients met our selection criteria. Meta-analysis results among 10 case-control studies showed that the combined HR was &#x02212;2.83 [95% confidence interval (CI) &#x02212;2.92, &#x02212;2.73; <italic>P</italic>&#x0200a;&#x0003c;&#x0200a;.0001], indicating a 2.83-fold decrease of pain in PVP group. For 12 single-arm studies, a significantly decrease of pain after PVP treatment (HR&#x0200a;=&#x0200a;&#x02212;4.79, 95% CI &#x02212;5.00, &#x02212;4.57, <italic>P</italic>&#x0200a;&#x0003c;&#x0200a;.0001) was also found in PVP group. In addition, for KPS analysis, the combined HR was 16.31 (95% CI 14.31, 18.31; <italic>P</italic>&#x0200a;&#x0003c;&#x0200a;.0001), which indicated that PVP treatment was associated with a 16.31-fold increase of KPS. The combined HR was 0.58 (95% CI 0.35, 0.96; <italic>P</italic>&#x0200a;=&#x0200a;.04) for complication analysis.</p></sec><sec sec-type="conclusion"><title>Conclusions:</title><p>PVP treatment of spinal tumor is significantly associated with better pain relief and life quality, which could improve the outcome in metastatic spinal tumor patients.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>efficacy</kwd><kwd>meta-analysis</kwd><kwd>spinal tumors</kwd><kwd>vertebroplasty</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec><label>1</label><title>Introduction</title><p>Bone disease contributes substantially to morbidity and mortality in patients with cancer. Based on the statistics from the American Cancer Society, there will be 2970 new cases and 1490 deaths of cancer of the bones and joints in 2015.<sup>[<xref rid="R1" ref-type="bibr">1</xref>]</sup> Thus, bone tumors are posing a potential threat to public health and seeking for an efficient strategy is of great significance.</p><p>Percutaneous vertebroplasty (PVP), initially described in patients with symptomatic vertebral hemangioma, has been established as a safe and effective treatment for osteoporotic vertebral fractures and vertebral metastatic lesions.<sup>[<xref rid="R2" ref-type="bibr">2</xref>]</sup> Compared with radiotherapy alone, this procedure provides immediate structural support, and stabilizes and reinforces the remaining bone structure.<sup>[<xref rid="R3" ref-type="bibr">3</xref>]</sup> The conflicting conclusions might result from the rarity of bone tumor cases. When the sample size was not enough, the statistical power to gain the underlying answer would be low and the probability to make mistakes would be considerable.</p><p>To provide a theoretical basis for the prevention of bone tumor, a meta-analysis was performed to pool all relevant published data to investigate the efficacy of PVP for the treatment of spinal tumors.</p></sec><sec><label>2</label><title>Methods</title><sec><label>2.1</label><title>Search strategy</title><p>We searched the electronic databases PubMed, Embase, and the Chinese Biomedical literature database from January 1, 2009 to December 31, 2015. The keywords &#x0201c;spinal tumors,&#x0201d; &#x0201c;efficacy,&#x0201d; and &#x0201c;vertebroplasty&#x0201d; were firstly scanned to exclude all irrelevant papers. Then, the final inclusion of studies was determined by reading the full text of the remaining articles. The citation lists of all retrieved articles were scanned to identify other potentially relevant reports.</p></sec><sec><label>2.2</label><title>Selection criteria</title><p>The search results were screened according to specific inclusion and exclusion criteria as follows. Inclusion criteria: research limited to human bone tumor; the study was published in English or Chinese; evaluation of pain relief; peer-reviewed and published original articles; and letters reporting original research work. Exclusion criteria: key information was incomplete to provide the required data; nonoriginal researches, letters referring comments or opinions to articles, reviews, and articles published in a book. If patients were enrolled from the same institutions during the same period, the most recently published data were included in the study.</p></sec><sec><label>2.3</label><title>Data extraction</title><p>Titles and abstracts were screened for eligibility. Two reviewers performed the search and assessed the studies independently, and the inclusion of a study was decided by consensus. The following items were recorded from each study: the first author's name, year of publication, language, cohort size, diagnosis, and follow-up time.</p></sec><sec><label>2.4</label><title>Statistical analysis</title><p>After collecting and classifying the information, the data were analyzed utilizing SPSS version 13.0.</p><p>Data combining was performed using RevMan version 5.2 (free software downloaded from <ext-link ext-link-type="uri" xlink:href="http://www.cochrane.org/">http://www.cochrane.org</ext-link>). Heterogeneity across studies was evaluated by the <italic>I</italic><sup>2</sup> statistic, which represents the percentage of total variation across studies that is attributable to heterogeneity rather than to chance.</p></sec></sec><sec><label>3</label><title>Results</title><sec><label>3.1</label><title>Description of studies</title><p>As shown in Figure <xref ref-type="fig" rid="F1">1</xref>, 108 articles were identified, of which 82 articles were excluded after screening titles or abstracts because they were irrelevant to this study or unsuitable for the inclusive criteria. Finally, 22 studies were included into this study with 10 studies of case-control study, 12 studies of single-arm studies for visual analog scale (VAS) studies and 4 studies for Karnofsky performance scores (KPS) analysis.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Flow chart of the literature search strategy to identify cohort studies on breast cancer risk and physical activity.</p></caption><graphic xlink:href="medi-97-e9575-g001"/></fig></sec><sec><label>3.2</label><title>Meta-analysis of pain relief after PVP treatment among case-control studies</title><p>Pain relief, assessed by VAS score, was analyzed in 10 case-control studies and in a total of 690 cases (Table <xref ref-type="table" rid="T1">1</xref>).<sup>[<xref rid="R4" ref-type="bibr">4</xref>&#x02013;<xref rid="R13" ref-type="bibr">13</xref>]</sup> The results showed significant between-study heterogeneity (<italic>P</italic>&#x0200a;&#x0003c;&#x0200a;.0001, <italic>I</italic><sup><italic>2</italic></sup>&#x0200a;=&#x0200a;98%), and a random-effects model was used. The combined HR (hazard ratio) was &#x02212;2.83 [95% confidence interval (CI) &#x02212;2.92, &#x02212;2.73; <italic>P</italic>&#x0200a;&#x0003c;&#x0200a;.0001] (Fig. <xref ref-type="fig" rid="F2">2</xref>A), which indicated that PVP treatment was associated with a 2.83-fold decreased risk of pain, in comparison with control studies. Patients exhibited excellent improvement of pain during the follow-up.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Characteristics of the case-control studies evaluating VAS scores<sup>[<xref rid="R4" ref-type="bibr">4</xref>&#x02013;<xref rid="R13" ref-type="bibr">13</xref>]</sup>.</p></caption><graphic xlink:href="medi-97-e9575-g002"/></table-wrap><fig id="F2" position="float"><label>Figure 2</label><caption><p>Results of meta-analysis. A, Forest plot of the hazard ratio (HR) for VAS among case-control studies (B) Forest plot of the hazard ratio (HR) for VAS among single-arms studies (C) Forest plot of the hazard ratio (HR) for KPS among studies (D) Forest plot of the hazard ratio (HR) for compliance.</p></caption><graphic xlink:href="medi-97-e9575-g003"/></fig></sec><sec><label>3.3</label><title>Pain relief before and after treatment by PVP among single-arms studies</title><p>As shown in Table <xref ref-type="table" rid="T2">2</xref>,<sup>[<xref rid="R14" ref-type="bibr">14</xref>&#x02013;<xref rid="R25" ref-type="bibr">25</xref>]</sup> there are 12 single-arm studies with 534 cases included, evaluating the efficacy of PVP to pain scales in tumor patients. The VAS score was evaluated respectively, before and after treatment of PVP. A random-effects model was used to combine HRs because of the heterogeneity among the studies (<italic>P</italic>&#x0200a;&#x0003c;&#x0200a;.0001; <italic>I</italic><sup><italic>2</italic></sup>&#x0200a;=&#x0200a;89%). Identically, the results of the meta-analysis showed a significantly decrease of pain after PVP treatment (HR&#x0200a;=&#x0200a;&#x02212;4.79, 95% CI &#x02212;5.00, &#x02212;4.57, <italic>P</italic>&#x0200a;&#x0003c;&#x0200a;.0001) (Fig. <xref ref-type="fig" rid="F2">2</xref>B).</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Characteristics of the single-arms studies according to VAS relief<sup>[<xref rid="R14" ref-type="bibr">14</xref>&#x02013;<xref rid="R25" ref-type="bibr">25</xref>]</sup>.</p></caption><graphic xlink:href="medi-97-e9575-g004"/></table-wrap></sec><sec><label>3.4</label><title>Meta-analysis results of KPS</title><p>Four studies including 127 cases evaluated the impact of PVP on the KPS of patients (Table <xref ref-type="table" rid="T3">3</xref>).<sup>[<xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R25" ref-type="bibr">25</xref>]</sup> The results showed significant between-study heterogeneity (<italic>P</italic>&#x0200a;&#x0003c;&#x0200a;.0001, <italic>I</italic><sup><italic>2</italic></sup>&#x0200a;=&#x0200a;94%), and a random-effects model was used. The combined HR was 16.31 (95% CI 14.31, 18.31; <italic>P</italic>&#x0200a;&#x0003c;&#x0200a;.0001) (Fig. <xref ref-type="fig" rid="F2">2</xref>C), which indicated that PVP treatment was associated with a 16.31-fold increase of KPS (Fig. <xref ref-type="fig" rid="F3">3</xref>).</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Characteristics of studies included in the meta-analysis according to KPS scales<sup>[<xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R25" ref-type="bibr">25</xref>]</sup>.</p></caption><graphic xlink:href="medi-97-e9575-g005"/></table-wrap><fig id="F3" position="float"><label>Figure 3</label><caption><p>Funnel plot for VAS in case-control studies (A), single-arm studies (B), and KPS (C).</p></caption><graphic xlink:href="medi-97-e9575-g006"/></fig></sec><sec><label>3.5</label><title>Complications</title><p>Five studies including 217 cases evaluated the impact of PVP on the complications of patients. The results showed significant between-study heterogeneity (<italic>P</italic>&#x0200a;=&#x0200a;.008, <italic>I</italic><sup><italic>2</italic></sup>&#x0200a;=&#x0200a;71%), and a random-effects model was used. The combined HR was 0.58 (95% CI 0.35, 0.96; <italic>P</italic>&#x0200a;=&#x0200a;.04) (Fig. <xref ref-type="fig" rid="F2">2</xref>D).</p></sec><sec><label>3.6</label><title>Publication bias</title><p>Twelve studies evaluating VAS/KPS were examined by Begg test. Visual inspection of the funnel plot showed asymmetry suggesting publication bias. Sensitivity analysis was performed using the trim and fill method, which conservatively imputes hypothetical negative unpublished studies or omits certain studies to mirror the positive studies that cause funnel plot asymmetry.</p></sec></sec><sec><label>4</label><title>Discussion</title><p>Bone is the third most common site for metastatic disease (after lung and liver).<sup>[<xref rid="R26" ref-type="bibr">26</xref>]</sup> As reported, spinal metastatic disease occurs in up to one-third of all cancer patients, like breast, prostate, lung, kidney, or thyroid cancers. Notorious for causing severe pain, bone metastases are also the major reasons for pathologic fracture, life-threatening hypercalcemia, spinal cord compression, immobility, and ultimate mortality in patients affiliated with advanced cancers.<sup>[<xref rid="R27" ref-type="bibr">27</xref>]</sup>A lot of progress has been made in the medical management of bone metastases including surgery approaches and radiation therapy, and targeted medical therapy. However, these strategies are at best only palliative and do not improve overall patient survival.<sup>[<xref rid="R28" ref-type="bibr">28</xref>]</sup> Metastatic disease of the spine can manifest in many ways. Pain is present in virtually all cases and can be severe enough that basic activities such as walking become nearly impossible. The challenges to identify more effective and specific molecularly targeted therapy to prevent and cure bone metastases and enhance the quality of life in these patients remain daunting. In this study, the included participants were overall metastatic spinal tumor.</p><p>PVP is a well-known percutaneous procedure effective in relieving pain, in comparison with open surgery. According to the guidelines published by the Society of Interventional Radiology (SIR) in 2003, the common indications for PV include osteoporotic vertebral compression fracture older than 2 weeks and refractory by medical therapy, painful vertebra with extensive osteolysis or invasion secondary to benign or malignant tumor, and painful vertebral fractures associated with osteonecrosis.<sup>[<xref rid="R29" ref-type="bibr">29</xref>]</sup> In 2009, the American College of Radiology (ACR), the American Society of Neuroradiology (ASNR), the Society of Neurointerventional Surgery (SNIS), the American Society of Spine Radiology (ASSR), and the SIR collaboratively prepared the official practice guidelines for vertebroplasty.<sup>[<xref rid="R30" ref-type="bibr">30</xref>]</sup> Presently, a meta-analysis was proceeded to evaluate the efficacy of PVP to pain relief. Pain assessment according to VAS was performed for all 22 included studies. Sensitivity analyses were performed to ensure that the results were reliable and valid. Finally, results indicated a significant decrease of pain scales after PVP treatment, implying the efficacy of PVP in pain relief of metastatic spinal tumor patients. In addition, life quality assessment according to KPS was performed for 4 studies and the KPS score was improved outstandingly after PVP treatment. In contrast, the complication rate was increased in PVP group. But the result may be inaccurate, because PVP group was mostly regarded as control other than experimental group in the study, in comparison with PKP (percutaneous kyphoplasty). Recently, several studies have proved the better safety of PKP than PVP. However, PKP has a longer operation time and higher material cost than PVP.<sup>[<xref rid="R31" ref-type="bibr">31</xref>]</sup> To confirm this evaluation, a large multi-center randomized controlled trial (RCT) should be conducted.</p><p>We acknowledge certain limitations of our study. First is the lack of a control group undergoing conservative treatment or PVP, especially with respect to the incidence of cement leakage. Second, the participants were relatively small. Third, the general status, previous treatment, life expectancy, and tumor type of the cancer patient may all influence the treatment outcome. With much more studies being published, the influence factors of PVP treatment efficacy should be explored in the near future. Because of limited evidence regarding the therapeutic aspects of these tumors, no definite protocol can be formulated for their treatment and the best mode of therapy should be individualized for each case. Additional high-quality data are necessary to draw more reliable conclusions.</p><p>In conclusion, our comprehensive meta-analysis of all published studies showed that PVP is significantly associated with pain relief and life quality in metastatic spinal tumor patients. It seems that PVP can improve the outcome in these patients.</p></sec></body><back><fn-group><fn fn-type="abbr"><p>Abbreviations: ACP = American College of Radiology, ASNR = American Society of Neuroradiology, ASSR = American Society of Spine Radiology, CI = confidence interval, HRs = hazard ratio, KPS = Karnofsky performance scores, PVP = percutaneous vertebroplasty, SIR = Society of Interventional Radiology, SNIS = Society of Neurointerventional Surgery, VAS = visual analog scale.</p></fn><fn fn-type="supported-by"><p>This research was supported by grants from the National Science Foundation of China (81302313).</p></fn><fn fn-type="COI-statement"><p>The authors declare conflict of interests.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegel</surname><given-names>RL</given-names></name><name><surname>Miller</surname><given-names>KD</given-names></name><name><surname>Jemal</surname><given-names>A</given-names></name></person-group>
<article-title>Cancer statistics, 2015</article-title>. <source>CA Cancer J Clin</source>
<year>2015</year>;<volume>65</volume>:<fpage>5</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="pmid">25559415</pub-id></mixed-citation></ref><ref id="R2"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chew</surname><given-names>C</given-names></name><name><surname>Craig</surname><given-names>L</given-names></name><name><surname>Edwards</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Safety and efficacy of percutaneous vertebroplasty in malignancy: a systematic review</article-title>. <source>Clin Radiol</source>
<year>2011</year>;<volume>66</volume>:<fpage>63</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="pmid">21147301</pub-id></mixed-citation></ref><ref id="R3"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>HQ</given-names></name><name><surname>Yang</surname><given-names>HL</given-names></name><name><surname>Geng</surname><given-names>DC</given-names></name><etal/></person-group>
<article-title>Spinal extradural arachnoid cyst following percutaneous vertebroplasty</article-title>. <source>Eur Spine J</source>
<year>2011</year>;<volume>20</volume><issue>(Suppl 2)</issue>:<fpage>S206</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="pmid">20835874</pub-id></mixed-citation></ref><ref id="R4"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ke</surname><given-names>ZY</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhong</surname><given-names>YL</given-names></name><etal/></person-group>
<article-title>Percutaneous vertebroplasty combined with percutaneous pediculoplasty for lytic vertebral body and pedicle lesions of metastatic tumors</article-title>. <source>Pain Physician</source>
<year>2015</year>;<volume>18</volume>:<fpage>E347</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="pmid">26000681</pub-id></mixed-citation></ref><ref id="R5"><label>[5]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Xie</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Treatment of metastatic spinal tumors by percutaneous vertebroplasty versus percutaneous vertebroplasty combined with interstitial implantation of 125I seeds</article-title>. <source>Acta Radiol</source>
<year>2009</year>;<volume>50</volume>:<fpage>1142</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">19922311</pub-id></mixed-citation></ref><ref id="R6"><label>[6]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Tan</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Clinical investigations on the spinal osteoblastic metastasis treated by combination of percutaneous vertebroplasty and (125)I seeds implantation versus radiotherapy</article-title>. <source>Cancer Biother Radiopharm</source>
<year>2013</year>;<volume>28</volume>:<fpage>58</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="pmid">23009581</pub-id></mixed-citation></ref><ref id="R7"><label>[7]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Tan</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Treatment of MM-associated spinal fracture with percutaneous vertebroplasty (PVP) and chemotherapy</article-title>. <source>Eur Spine JV 21</source>
<year>2012</year>;<fpage>912</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="R8"><label>[8]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>L</given-names></name><name><surname>Shen</surname><given-names>LD</given-names></name><name><surname>Yang</surname><given-names>ZZ</given-names></name><etal/></person-group>
<article-title>Clinical observation on patients with lung cancer and breast cancer with spinal metastasis by percutaneous vertebroplasty combined with docetaxel and cisplatin</article-title>. <source>China J Cancer Prev Treat</source>
<year>2009</year>;<volume>5</volume>:<fpage>371</fpage>&#x02013;<lpage>3</lpage>.</mixed-citation></ref><ref id="R9"><label>[9]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>JH</given-names></name><name><surname>Huang</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>CH</given-names></name><etal/></person-group>
<article-title>The effect comparison of perctaneous vertebroplasty with kyphoplasty in the treatment of multi-segmental thoracic and lumbar spinal metastases</article-title>. <source>J Bengbu Med Coll</source>
<year>2014</year>;<volume>7</volume>:<fpage>924</fpage>&#x02013;<lpage>6</lpage>.</mixed-citation></ref><ref id="R10"><label>[10]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>YW</given-names></name><name><surname>Ni</surname><given-names>FC</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Clinical application of percutaneous vertebroplasty and kyphoplasty in treating malignant tumors of spine</article-title>. <source>J Intervent Radiot</source>
<year>2012</year>;<volume>6</volume>:<fpage>478</fpage>&#x02013;<lpage>81</lpage>.</mixed-citation></ref><ref id="R11"><label>[11]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>QY</given-names></name><name><surname>Han</surname><given-names>K</given-names></name><name><surname>Gao</surname><given-names>HR</given-names></name><etal/></person-group>
<article-title>Comparison of the clinical efficacy of percutaneous vertebroplasty and percutaneous kyphoplasty in the treatment of vertebral hemangioma</article-title>. <source>Progress in modern biomedicine</source>
<year>2015</year>;<volume>22</volume>:<fpage>4279</fpage>&#x02013;<lpage>82</lpage>.</mixed-citation></ref><ref id="R12"><label>[12]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>YL</given-names></name></person-group>
<article-title>Clinical application of percutaneous vertebroplasty in treating malignant tumors and metastases tumor of spine</article-title>. <source>China Foreign Med Treatm</source>
<year>2014</year>;<volume>21</volume>:<fpage>71</fpage>&#x02013;<lpage>2</lpage>.</mixed-citation></ref><ref id="R13"><label>[13]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>He</surname><given-names>XJ</given-names></name></person-group>
<article-title>Study on the effect of percutaneous vertebroplasty in the treatment of spinal tumor and vertebral metastases</article-title>. <source>J Med Theor Prac</source>
<year>2015</year>;<volume>8</volume>:<fpage>995</fpage>&#x02013;<lpage>6</lpage>.</mixed-citation></ref><ref id="R14"><label>[14]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Safety of percutaneous vertebroplasty for the treatment of metastatic spinal tumors in patients with posterior wall defects</article-title>. <source>Eur Spine J</source>
<year>2015</year>;<volume>24</volume>:<fpage>1768</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="pmid">25694161</pub-id></mixed-citation></ref><ref id="R15"><label>[15]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>YF</given-names></name><name><surname>Li</surname><given-names>YD</given-names></name><name><surname>Wu</surname><given-names>CG</given-names></name><etal/></person-group>
<article-title>Safety and efficacy of percutaneous vertebroplasty and interventional tumor removal for metastatic spinal tumors and malignant vertebral compression fractures</article-title>. <source>AJR Am J Roentgenol</source>
<year>2014</year>;<volume>202</volume>:<fpage>W298</fpage>&#x02013;<lpage>305</lpage>.<pub-id pub-id-type="pmid">24555629</pub-id></mixed-citation></ref><ref id="R16"><label>[16]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Yan</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Transarterial chemoembolization for pain relief in patients with hypervascular painful metastatic spinal tumors refractory to percutaneous vertebroplasty</article-title>. <source>J Cancer Res Clin Oncol</source>
<year>2013</year>;<volume>139</volume>:<fpage>1343</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">23677284</pub-id></mixed-citation></ref><ref id="R17"><label>[17]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farrokhi</surname><given-names>M</given-names></name><name><surname>Nouraei</surname><given-names>H</given-names></name><name><surname>Kiani</surname><given-names>A</given-names></name></person-group>
<article-title>The efficacy of percutaneous vertebroplasty in pain relief in patients with pathological vertebral fractures due to metastatic spinal tumors</article-title>. <source>Iran Red Crescent Med J</source>
<year>2012</year>;<volume>14</volume>:<fpage>523</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">23115714</pub-id></mixed-citation></ref><ref id="R18"><label>[18]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Han</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Percutaneous vertebroplasty combined with zoledronic acid for the treatment of painful osteolytic spinal metastases in patients with breast cancer</article-title>. <source>J Vasc Interv Radiol</source>
<year>2013</year>;<volume>24</volume>:<fpage>1861</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">24144536</pub-id></mixed-citation></ref><ref id="R19"><label>[19]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>KW</given-names></name><name><surname>Wang</surname><given-names>HK</given-names></name><name><surname>Lu</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Fluoroscopically guided C2 percutaneous vertebroplasty: a surgical technique note on an anterior ascending approach</article-title>. <source>Pain Physician</source>
<year>2016</year>;<volume>19</volume>:<fpage>E625</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">27228529</pub-id></mixed-citation></ref><ref id="R20"><label>[20]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trumm</surname><given-names>CG</given-names></name><name><surname>Pahl</surname><given-names>A</given-names></name><name><surname>Helmberger</surname><given-names>TK</given-names></name><etal/></person-group>
<article-title>CT fluoroscopy-guided percutaneous vertebroplasty in spinal malignancy: technical results, PMMA leakages, and complications in 202 patients</article-title>. <source>Skeletal Radiol</source>
<year>2012</year>;<volume>41</volume>:<fpage>1391</fpage>&#x02013;<lpage>400</lpage>.<pub-id pub-id-type="pmid">22286549</pub-id></mixed-citation></ref><ref id="R21"><label>[21]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chew</surname><given-names>C</given-names></name><name><surname>Ritchie</surname><given-names>M</given-names></name><name><surname>O&#x02019;Dwyer</surname><given-names>PJ</given-names></name><etal/></person-group>
<article-title>A prospective study of percutaneous vertebroplasty in patients with myeloma and spinal metastases</article-title>. <source>Clin Radiol</source>
<year>2011</year>;<volume>66</volume>:<fpage>1193</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">21968026</pub-id></mixed-citation></ref><ref id="R22"><label>[22]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jian</surname><given-names>W</given-names></name></person-group>
<article-title>Symptomatic cervical vertebral hemangioma treated by percutaneous vertebroplasty</article-title>. <source>Pain physician</source>
<year>2013</year>;<volume>16</volume>:<fpage>E419</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="pmid">23877466</pub-id></mixed-citation></ref><ref id="R23"><label>[23]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>BS</given-names></name><name><surname>Chang</surname><given-names>UK</given-names></name><name><surname>Youn</surname><given-names>SM</given-names></name></person-group>
<article-title>Clinical outcomes after percutaneous vertebroplasty for pathologic compression fractures in osteolytic metastatic spinal disease</article-title>. <source>J Korean Neurosurg Soc</source>
<year>2009</year>;<volume>45</volume>:<fpage>369</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="pmid">19609421</pub-id></mixed-citation></ref><ref id="R24"><label>[24]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>HT</given-names></name><name><surname>Hu</surname><given-names>CD</given-names></name><name><surname>Chen</surname><given-names>HZ</given-names></name><etal/></person-group>
<article-title>Clinical effective of percutaneous vertebroplasty combined with pharmorublcin cement in the treatment of spinal metastases</article-title>. <source>Chin J Clin Oncol Rehabil</source>
<year>2013</year>;<volume>5</volume>:<fpage>530</fpage>&#x02013;<lpage>2</lpage>.</mixed-citation></ref><ref id="R25"><label>[25]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>QH</given-names></name><name><surname>Wu</surname><given-names>HG</given-names></name><name><surname>Gu</surname><given-names>YF</given-names></name><etal/></person-group>
<article-title>Clinical application of percytaneous certebroplasty in treating osteoblastic spinal metastases</article-title>. <source>J Intervent Radiol</source>
<year>2014</year>;<volume>5</volume>:<fpage>411</fpage>&#x02013;<lpage>4</lpage>.</mixed-citation></ref><ref id="R26"><label>[26]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davila</surname><given-names>D</given-names></name><name><surname>Antoniou</surname><given-names>A</given-names></name><name><surname>Chaudhry</surname><given-names>MA</given-names></name></person-group>
<article-title>Evaluation of osseous metastasis in bone scintigraphy</article-title>. <source>Semin Nucl Med</source>
<year>2015</year>;<volume>45</volume>:<fpage>3</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="pmid">25475375</pub-id></mixed-citation></ref><ref id="R27"><label>[27]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinn</surname><given-names>RH</given-names></name><name><surname>Randall</surname><given-names>RL</given-names></name><name><surname>Benevenia</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Contemporary management of metastatic bone disease: tips and tools of the trade for general practitioners</article-title>. <source>Instr Course Lect</source>
<year>2014</year>;<volume>63</volume>:<fpage>431</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="pmid">24720328</pub-id></mixed-citation></ref><ref id="R28"><label>[28]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taubenberger</surname><given-names>AV</given-names></name></person-group>
<article-title>In vitro microenvironments to study breast cancer bone colonisation</article-title>. <source>Adv Drug Deliv Rev</source>
<year>2014</year>;<volume>79&#x02013;80</volume>:<fpage>135</fpage>&#x02013;<lpage>44</lpage>.</mixed-citation></ref><ref id="R29"><label>[29]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGraw</surname><given-names>JK</given-names></name><name><surname>Cardella</surname><given-names>J</given-names></name><name><surname>Fau-Barr</surname><given-names>JD</given-names></name><etal/></person-group>
<article-title>Society of interventional radiology quality improvement guidelines for percutaneous vertebroplasty</article-title>. <source>J Vasc Interv Radiol</source>
<year>2003</year>;<volume>14</volume>:<fpage>827</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">12847189</pub-id></mixed-citation></ref><ref id="R30"><label>[30]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helmberger</surname><given-names>T</given-names></name><name><surname>Bohndorf</surname><given-names>K</given-names></name><name><surname>Hierholzer</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Guidelines of the German Radiological Society for percutaneous vertebroplasty</article-title>. <source>Der Radiologe</source>
<year>2003</year>;<volume>43</volume>:<fpage>703</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">14517599</pub-id></mixed-citation></ref><ref id="R31"><label>[31]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Sribastav</surname><given-names>SS</given-names></name><name><surname>Ye</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>Comparison of percutaneous vertebroplasty and balloon kyphoplasty for the treatment of single level vertebral compression fractures: a meta-analysis of the literature</article-title>. <source>Pain Physician</source>
<year>2015</year>;<volume>18</volume>:<fpage>209</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">26000665</pub-id></mixed-citation></ref></ref-list></back></article>